MERRIMACK PHARMACEUTICALS INC·4

Feb 13, 4:06 PM ET

MERRIMACK PHARMACEUTICALS INC 4

4 · MERRIMACK PHARMACEUTICALS INC · Filed Feb 13, 2014

Insider Transaction Report

Form 4
Period: 2014-02-11
Khan Fazal R.
SVP of Manufacturing
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2014-02-11+75,00075,000 total
    Exercise: $5.02Exp: 2024-02-10Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 1/12th of the total number of shares on 5/11/14 and an additional 1/12th of the total number of shares at the end of each successive three month period thereafter until 2/11/17.
Signature
/s/ Jeffrey A. Munsie, attorney-in-fact|2014-02-13

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -